[GBC-Dynamic BIO] ¹ÙÀÌ¿ÀÇコ Çã°¡ ±ÔÁ¦ µ¿Çâ ¼¼¹Ì³ª
°¡. ÀϽÃ: '22.9.7. (¼ö) 10:00 - 11:00
³ª. Àå¼Ò: ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F, ·ÎÁî·ë
´Ù. Âü¼®Àοø: ´ÙÀ̳ª¹Í¹ÙÀÌ¿À ºÐ°ú¿ø, ½Ä¾àó, Çùȸ µî
¶ó. ¹ßÇ¥³»¿ë
(1) Ç×¾ÏÀǾàÇ° ÇØ¿Ü °øµ¿Çã°¡ ½É»ç »ç·Ê °øÀ¯ - Çѱ¹MSD ¹ÚÈñÀ± ºÎÀå
(2) Çõ½ÅÀÇ·á±â±âÀÇ ¹Ì±¹ ½ÃÀå ÁøÀÔÀ» À§ÇÑ ³ë·Â - ·ç´Ö ¹Ú½Â±Õ CPO
[Âü°í] ¼¼¹Ì³ª »çÁø
[GBC-Dynamic BIO] ¹ÙÀÌ¿ÀÀǾàÇ° Á¤Ã¥ Æ÷·³
°¡. ÀϽÃ: '22.9.7. (¼ö) 14:00 - 15:00
³ª. Àå¼Ò: ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F, ·ÎÁî·ë
´Ù. Âü¼®Àοø: ´ÙÀ̳ª¹Í¹ÙÀÌ¿À ºÐ°ú¿ø, ½Ä¾àó, Çùȸ µî
¶ó. ÆгÎÅä·Ð
(1) Çã°¡º¯°æ ¾÷¹« ±âÁØ °³¼±À» ÅëÇÑ È¿À²¼º Á¦°í - SK¹ÙÀÌ¿À»çÀ̾𽺠¹ÚÁ¾±¹ ÆÀÀå
(2) FDA expedited pathwayÀÇ Çѱ¹Çü ÇÁ·Î¼¼½º ±¸Ãà ¹× Àû¿ë - GC³ì½ÊÀÚ ÀÌÀç¿ì »ó¹«
(3) ½Å¾à°³¹ß ºÐ¾ß µðÁöÅÐ Àüȯ °¡¼ÓÈ Áö¿ø - KISTEP ±èÀºÁ¤ ¼¾ÅÍÀå
(4) ¹ÙÀÌ¿ÀÀǾàÇ°»ê¾÷ Á¤Ã¥ÀÇ ÅëÇÕ¡¤¿¬°è °Å¹ö³Í½º ±¸Ãà - KIET ÃÖÀ±Èñ ¼±ÀÓ¿¬±¸À§¿ø
(5) Buffalo theory in Biotherapeutics development - ¼¿ï´ëÇб³ ÀÌÀåÀÍ ±³¼ö
(6) ÀÇ·áÁ¦Ç° ±Û·Î¹ú ±ÔÁ¦Á¶ÈÀÇ ½ÇÁúÀûÀÎ ÃßÁø - KFDC ¼Õ¿©¿ø ȸÀå
[Âü°í] Æ÷·³ »çÁø